Keywords: fda, clears, risperdal, new, indications, food, drug

FDA clears Risperdal for two new indications

Article | 03 September 2007

Print This

The US Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents ages 13-17 and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in